Association of Body Mass Index and Abdominal Obesity with the Risk of Airflow Obstruction: National Health and Nutrition Examination Survey (NHANES) 2007–2012

References

• Eschenbacher WL. Defining airflow obstruction. J Copd F. 2016;3(2):515–518. DOI:10.15326/jcopdf.3.2.2015.0166
   PubMedGoogle Scholar
• Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(3):228–237. DOI:10.1164/rccm.201210-1843CI
   PubMed Web of Science ®Google Scholar
• Thurlbeck WM. Pathology of chronic airflow obstruction. Chest. 1990;97(2 Suppl):6s–10s. DOI:10.1016/S0012-3692(15)41137-7
   PubMed Web of Science ®Google Scholar
• Garcia B, Flume PA. Pulmonary complications of cystic fibrosis. Semin Respir Crit Care Med. 2019;40(6):804–809. DOI:10.1055/s-0039-1697639
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. DOI:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Criner RN, Han MK. COPD care in the 21st century: a public health priority. Respir Care. 2018;63(5):591–600. DOI:10.4187/respcare.06276
   PubMed Web of Science ®Google Scholar
• Wang H, Liu X, Umino T, et al. Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol. 2001;25(6):772–779. DOI:10.1165/ajrcmb.25.6.4458
   PubMed Web of Science ®Google Scholar
• Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab. 2015;66(Suppl 2):7–12. DOI:10.1159/000375143
   PubMed Web of Science ®Google Scholar
• Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10. DOI:10.1016/j.metabol.2018.09.005
   PubMed Web of Science ®Google Scholar
• Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755–767. DOI:10.1080/17476348.2018.1506331
   PubMed Web of Science ®Google Scholar
• He H, Wang B, Zhou M, et al. Systemic inflammation mediates the associations between abdominal obesity indices and lung function decline in a Chinese general population. DMSO. 2020;13:141–150. DOI:10.2147/DMSO.S229749
   Google Scholar
• Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009;179(6):509–516. DOI:10.1164/rccm.200807-1195OC
   PubMed Web of Science ®Google Scholar
• WHO Consultation on Obesity (1999: Geneva, Switzerland) and World Health Organization. Obesity : preventing and managing the global epidemic: report of a WHO consultation. World Health Organization; 2000. WHO technical report series. 894, 252 p. https://apps.who.int/iris/handle/10665/42330
   Google Scholar
• Han TS, McNeill G, Seidell JC, et al. Predicting intra-abdominal fatness from anthropometric measures: the influence of stature. Int J Obes Relat Metab Disord. 1997;21(7):587–593. DOI:10.1038/sj.ijo.0800446
   PubMed Web of Science ®Google Scholar
• Christopher DJ, Oommen AM, George K, et al. Prevalence of airflow obstruction as measured by spirometry, in rural Southern Indian adults. COPD. 2020;17(2):128–135. DOI:10.1080/15412555.2020.1723074
   PubMedGoogle Scholar
• Shin SH, Park J, Cho J, et al. Severity of airflow obstruction and work loss in a nationwide population of working age. Sci Rep. 2018;8(1):9674. DOI:10.1038/s41598-018-27999-6
   PubMedGoogle Scholar
• Bhatt SP, Sieren JC, Dransfield MT, et al. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax. 2014;69:409–414.
   PubMedGoogle Scholar
• Andersson T, Alfredsson L, Källberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575–579. DOI:10.1007/s10654-005-7835-x
   PubMed Web of Science ®Google Scholar
• Sun Y, Milne S, Jaw JE, et al. BMI is associated with FEV(1) decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res. 2019;20(1):236. DOI:10.1186/s12931-019-1209-5
   PubMed Web of Science ®Google Scholar
• Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–338. DOI:10.1164/rccm.200712-1869OC
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Brook RD, SUMMIT Investigators, et al. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet. 2016;387(10030):1817–1826. DOI:10.1016/S0140-6736(16)30069-1
   PubMed Web of Science ®Google Scholar
• Gosker HR, Wouters EF, van der Vusse GJ, et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000;71(5):1033–1047. DOI:10.1093/ajcn/71.5.1033
   PubMed Web of Science ®Google Scholar
• Rossi A, Aisanov Z, Avdeev S, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med. 2015;109(7):785–802. DOI:10.1016/j.rmed.2015.03.010
   PubMed Web of Science ®Google Scholar
• Gagnon P, Guenette JA, Langer D, et al. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:187–201.
   PubMed Web of Science ®Google Scholar
• Hanson C, Rutten EP, Wouters EFM, et al. Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:723–733. DOI:10.2147/COPD.S50111
   PubMed Web of Science ®Google Scholar
• Alter P, Rabe KF, Schulz H, et al. Influence of body mass on predicted values of static hyperinflation in COPD. COPD. 2018;13:2551–2555. DOI:10.2147/COPD.S164096
   Google Scholar
• Marti S, Muñoz X, Rios J, et al. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J. 2006;27(4):689–696. DOI:10.1183/09031936.06.00076405
   PubMed Web of Science ®Google Scholar
• Guenette JA, Jensen D, O’Donnell DE. Respiratory function and the obesity paradox. Curr Opin Clin Nutr Metab Care. 2010;13(6):618–624.
   PubMed Web of Science ®Google Scholar
• Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD. 2015;12(1):14–18. DOI:10.3109/15412555.2014.915934
   PubMedGoogle Scholar
• Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–1932. DOI:10.1016/j.jacc.2008.12.068
   PubMed Web of Science ®Google Scholar
• Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol (1985). 2010;108(1):206–211. DOI:10.1152/japplphysiol.00694.2009
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Deesomchok A, Lam Y-M, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest. 2011;140(2):461–468. DOI:10.1378/chest.10-2582
   PubMed Web of Science ®Google Scholar
• Çolak Y, Marott JL, Vestbo J, Lange P. Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the copenhagen city heart study. COPD. 2015;12(1):5–13. DOI:10.3109/15412555.2014.933955
   PubMedGoogle Scholar
• Canoy D, Luben R, Welch A, et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk study, United Kingdom. Am J Epidemiol. 2004;159(12):1140–1149. DOI:10.1093/aje/kwh155
   PubMed Web of Science ®Google Scholar
• Vatrella A, Calabrese C, Mattiello A, et al. Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort. Nutr Metab Cardiovasc Dis. 2016;26(7):643–648. DOI:10.1016/j.numecd.2015.12.013
   PubMed Web of Science ®Google Scholar
• Lam KB, Jordan RE, Jiang CQ, et al. Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort study. Eur Respir J. 2010;35(2):317–323. DOI:10.1183/09031936.00024709
   PubMed Web of Science ®Google Scholar
• Park BH, Park MS, Chang J, et al. Chronic obstructive pulmonary disease and metabolic syndrome: a nationwide survey in Korea. Int J Tuberc Lung Dis. 2012;16(5):694–700. DOI:10.5588/ijtld.11.0180
   PubMed Web of Science ®Google Scholar
• Melo LC, Silva MA, Calles AC. Obesity and lung function: a systematic review. Einstein (Sao Paulo). 2014;12(1):120–125. DOI:10.1590/s1679-45082014rw2691
   PubMedGoogle Scholar
• Fried SK, Lee MJ, Karastergiou K. Shaping fat distribution: New insights into the molecular determinants of depot- and sex-dependent adipose biology. Obesity (Silver Spring). 2015;23(7):1345–1352. DOI:10.1002/oby.21133
   PubMed Web of Science ®Google Scholar
• Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007;21(3):415–430. DOI:10.1016/j.beem.2007.04.007
   PubMed Web of Science ®Google Scholar
• Chang E, Varghese M, Singer K. Gender and sex differences in adipose tissue. Curr Diab Rep. 2018;18(9):69. DOI:10.1007/s11892-018-1031-3
   PubMed Web of Science ®Google Scholar
• Stevens J, Katz EG, Huxley RR. Associations between gender, age and waist circumference. Eur J Clin Nutr. 2010;64(1):6–15. DOI:10.1038/ejcn.2009.101
   PubMed Web of Science ®Google Scholar
• Smith SR, Lovejoy JC, Greenway F, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and ­visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50(4):425–435. DOI:10.1053/meta.2001.21693
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009;34(3):588–597. DOI:10.1183/09031936.00164608
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD. 2006;3(2):95–100. DOI:10.1080/15412550600651552
   PubMedGoogle Scholar
• Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117–1122. DOI:10.1183/09031936.02.00023202
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, ERS Global Lung Function Initiative, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. DOI:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Wollmer P, Engström G. Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study. Respir Med. 2013;107(9):1460–1462. DOI:10.1016/j.rmed.2013.06.016
   PubMed Web of Science ®Google Scholar
• Bhatt SP, Balte PP, Schwartz JE, et al. Discriminative accuracy of FEV1:FVC thresholds for COPD-Related hospitalization and mortality. JAMA. 2019;321(24):2438–2447. DOI:10.1001/jama.2019.7233
   PubMed Web of Science ®Google Scholar